Effects of Tanreqing Injection on ICU Mortality among ICU Patients Receiving Mechanical Ventilation: Time-Dependent Cox Regression Analysis of a Large Registry
Back to article page
Original Article|Updated:2023-08-29
|
Effects of Tanreqing Injection on ICU Mortality among ICU Patients Receiving Mechanical Ventilation: Time-Dependent Cox Regression Analysis of a Large Registry
Chinese Journal of Integrative MedicineVol. 29, Issue 9, Pages: 782-790(2023)
Affiliations:
1.Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu (610041), China
2.NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu (610041), China
3.Sichuan Center of Technology Innovation for Real World Data, Chengdu (610041), China
4.Intensive Care Unit, West China Hospital, Sichuan University, Chengdu (610041), China
5.Information Center, West China Hospital, Sichuan University, Chengdu (610041), China
WANG Wen, HE Qiao, WANG Ming-qi, et al. Effects of Tanreqing Injection on ICU Mortality among ICU Patients Receiving Mechanical Ventilation: Time-Dependent Cox Regression Analysis of a Large Registry. [J]. Chinese Journal of Integrative Medicine 29(9):782-790(2023)
DOI:
WANG Wen, HE Qiao, WANG Ming-qi, et al. Effects of Tanreqing Injection on ICU Mortality among ICU Patients Receiving Mechanical Ventilation: Time-Dependent Cox Regression Analysis of a Large Registry. [J]. Chinese Journal of Integrative Medicine 29(9):782-790(2023) DOI: 10.1007/s11655-023-3634-z.
Effects of Tanreqing Injection on ICU Mortality among ICU Patients Receiving Mechanical Ventilation: Time-Dependent Cox Regression Analysis of a Large Registry
To assess whether the use of Tanreqing (TRQ) Injection could show improvements in time to extubation
intensive care unit (ICU) mortality
ventilator-associated events (VAEs) and infection-related ventilator associated complication (IVAC) among patients receiving mechanical ventilation (MV).
Methods:
2
A time-dependent cox-regression analysis was conducted using data from a well-established registry of healthcare-associated infections at ICUs in China. Patients receiving continuous MV for 3 days or more were included. A time-varying exposure definition was used for TRQ Injection
which were recorded on daily basis. The outcomes included time to extubation
ICU mortality
VAEs and IVAC. Time-dependent Cox models were used to compare the clinical outcomes between TRQ Injection and non-use
after controlling for the influence of comorbidities/conditions and other medications with both fixed and time-varying covariates. For the analyses of time to extubation and ICU mortality
Fine-Gray competing risk models were also used to measure competing risks and outcomes of interest.
Results:
2
Overall
7
685 patients were included for the analyses of MV duration
and 7
273 patients for the analysis of ICU mortality. Compared to non-use
patients with TRQ Injection had a lower risk of ICU mortality [Hazards ratios (HR) 0.761
95% CI
0.581–0.997]
and was associated with a higher hazard for time to extubation (HR 1.105
95% CI
1.005–1.216)
suggesting a beneficial effect on shortened time to extubation. No significant differences were observed between TRQ Injection and non-use regarding VAEs (HR 1.057
95% CI
0.912–1.225) and IVAC (HR 1.177
95% CI
0.929–1.491). The effect estimates were robust when using alternative statistic models
applying alternative inclusion and exclusion criteria
and handling missing data by alternative approaches.
Conclusion:
2
Our findings suggested that the use of TRQ Injection might lower mortality and improve time to extubation among patients receiving MV
even after controlling for the factor that the use of TRQ changed over time.